Michael Buchanan - DR Horton Independent Director
| DHI Stock | USD 172.94 9.41 5.75% |
Director
Mr. Michael R. Buchanan is Independent Director of the Company. Mr. Buchanan has significant commercial banking experience with several banking institutions serving the real estate and homebuilding sectors. He retired from commercial banking in March 2002. From March 2002 to March 2003, Mr. Buchanan was engaged as a senior advisor to Banc of America Securities. From 1998 to March 2002, Mr. Buchanan was a Managing Director of Bank of America, an executive officer position in which he was head of its national real estate banking group. From 1990 to 1998, Mr. Buchanan was an Executive Vice President of NationsBank, which later merged with Bank of America. Mr. Buchanan was appointed to our Boards Audit Committee in July 2003, Nominating and Governance Committee in November 2003 and Compensation Committee in January 2004. Mr. Buchanan is a highly experienced commercial banker who served the real estate and homebuilding sectors. His experience in these areas allows him to provide the Board with both a broadbased and a granular perspective on the homebuilding industry. Mr. Buchanan also brings his experience of having served on a board of a real estate investment trust, thereby providing the Board with additional perspective on the real estate industry and serving on a board of directors. since 2003.
| Age | 73 |
| Tenure | 21 years |
| Address | 1341 Horton Circle, Arlington, TX, United States, 76011 |
| Phone | 817 390 8200 |
| Web | https://www.drhorton.com |
Michael Buchanan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Buchanan against DR Horton stock is an integral part of due diligence when investing in DR Horton. Michael Buchanan insider activity provides valuable insight into whether DR Horton is net buyers or sellers over its current business cycle. Note, DR Horton insiders must abide by specific rules, including filing SEC forms every time they buy or sell DR Horton'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Buchanan over six months ago Disposition of 2000 shares by Michael Buchanan of DR Horton at 150.7 subject to Rule 16b-3 | ||
Michael Buchanan over six months ago Acquisition by Michael Buchanan of 224 shares of DR Horton subject to Rule 16b-3 |
DR Horton Management Efficiency
The company has Return on Asset of 0.1113 % which means that on every $100 spent on assets, it made $0.1113 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1963 %, implying that it generated $0.1963 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.35, while Return On Tangible Assets are projected to decrease to 0.1. As of now, DR Horton's Total Current Assets are increasing as compared to previous years. The DR Horton's current Other Assets is estimated to increase to about 6.3 B, while Non Currrent Assets Other are forecasted to increase to (159.1 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Edward Boehne | Toll Brothers | 79 | |
| Michael Wood | KB Home | 72 | |
| John McLean | Toll Brothers | 51 | |
| Deborah Henretta | Meritage | 59 | |
| Robert Johnson | KB Home | 74 | |
| Raymond Oppel | Meritage | 64 | |
| Vincent Pagano | Hovnanian Enterprises | 70 | |
| Dorene Dominguez | KB Home | 58 | |
| Larry Sorsby | Hovnanian Enterprises | 69 | |
| Manuel Johnson | NVR Inc | 71 | |
| Lawrence Hilsheimer | Installed Building Products | 63 | |
| Norma Provencio | Beazer Homes USA | 63 | |
| Sherrill Hudson | Lennar | 78 | |
| Melquiades Martinez | NVR Inc | 74 | |
| Michael Odell | Meritage | 57 | |
| Joseph Keough | Meritage | 51 | |
| Richard Dreiling | PulteGroup | 67 | |
| Teri McClure | Lennar | 57 | |
| David Preiser | NVR Inc | 63 | |
| Jodeen Kozlak | KB Home | 57 | |
| Dana Bradford | Meritage | 56 | |
Management Performance
DR Horton Leadership Team
Elected by the shareholders, the DR Horton's board of directors comprises two types of representatives: DR Horton inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DHI. The board's role is to monitor DR Horton's management team and ensure that shareholders' interests are well served. DR Horton's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DR Horton's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Buchanan, Independent Director | ||
| Donald Horton, Executive Chairman of the Board | ||
| Maribess Miller, Independent Director | ||
| Michael Hewatt, Independent Director | ||
| Michael Murray, Co-Chief Operating Officer, Executive Vice President | ||
| Thomas Montano, Corporate VP | ||
| Aron Odom, Principal Accounting Officer | ||
| Tom Hill, President Region | ||
| Jessica Hansen, VP of Communications | ||
| Barbara Allen, Independent Director | ||
| David Auld, President, Chief Executive Officer | ||
| Bill Wheat, Chief Financial Officer, Executive Vice President | ||
| Paul Romanowski, Co-Chief Operating Officer, Executive Vice President | ||
| Benjamin Carson, Independent Director | ||
| Collin Dawson, Vice Treasurer | ||
| Bradley Anderson, Independent Director | ||
| Matt Farris, President Region |
DHI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DR Horton a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 53.98 B | ||||
| Shares Outstanding | 321.17 M | ||||
| Shares Owned By Insiders | 10.34 % | ||||
| Shares Owned By Institutions | 83.45 % | ||||
| Number Of Shares Shorted | 6.19 M | ||||
| Price To Earning | 5.10 X |
Currently Active Assets on Macroaxis
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 1.2 | Earnings Share 14.34 | Revenue Per Share 111.689 | Quarterly Revenue Growth (0.05) |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.